Reducing Fraud and Lowering Barriers to the Production of Drugs in Shortage by Outsourcing Facilities

In plain English

Food and Drug Administration (Department of Health and Human Services) has announced this as a forecast: an opportunity it expects to post. It is not open for applications yet.

Awards are up to $3,000,000 each, the agency expects to make 2 awards and estimated total program funding is $3,000,000.

Eligibility is described in the listing text (the "Others" category).

The listing says cost sharing or matching is not required.

Built only from the fields in the Grants.gov listing. Always confirm on the official listing.

• Others (see the eligibility details in the listing)

Additional eligibility information (excerpt from the listing):

Higher Education Institutions Public/State Controlled Institutions of Higher Education Private Institutions of Higher Education Nonprofits Other Than Institutions of Higher Education Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education) Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education) For-Profit Organizations Small Businesses For-Profit Organizations (Other than Small Businesses) Local Governments State Governments County Governments City or Township Governments Special District Governments Indian/Native American Tribal …

Excerpt from the official forecast on Grants.gov (shortened; read the full text on the official listing):

The goals of this grant are to better understand the landscape of drug shortage products, including those vulnerable to health fraud, and identify opportunities for outsourcing facilities to meet drug shortage needs to strengthen the supply chain. Funding would also support outsourcing facilities’ research and development of products that mitigate persistent drug shortages to increase supply of critical medications and stabilize the drug supply chain to prevent health fraud.

Read the full forecast on Grants.gov →